Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2023-08-17 Director's Dealing
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Jang Ji-woon) of PCL Inc. This type of filing is a standard regulatory requirement for reporting insider transactions or changes in share ownership by company directors and executives, which corresponds to the 'Director's Dealing' category.
2023-08-17 Korean
[기재정정]증권신고서(지분증권) (2023.08)
Audit Report / Information Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) amendment (정정신고서) filed by PCL Inc. It details corrections made to a previously submitted registration statement following the submission of a semi-annual report. The document contains specific tables comparing 'Before Correction' (정정 전) and 'After Correction' (정정 후) data, which is characteristic of a formal regulatory filing amendment. It does not fit the criteria for a standalone report (like 10-K or IR) but rather acts as a regulatory update to a registration statement. H1 2023
2023-08-16 Korean
[기재정정]투자설명서
Regulatory Filings Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서). It details specific amendments made to the prospectus following the submission of the company's semi-annual report (반기보고서). It is not an annual or interim report itself, but rather a regulatory filing that updates previously submitted disclosure materials. Therefore, it falls under the 'Regulatory Filings' category as a miscellaneous compliance document. H1 2023
2023-08-16 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for PCL, Inc. for the period ending June 30, 2023. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
유상증자1차발행가액결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding the determination of the first issue price for a paid-in capital increase (rights offering). It details the calculation methodology, the specific price per share, and the timeline for the final price determination. This falls under the category of capital structure changes and financing updates, specifically related to share issuance pricing.
2023-07-13 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from PCL Inc. regarding a decision on a capital increase (both paid-in and bonus issues). It details the purpose of funds, share issuance prices, subscription methods, and timelines. This type of filing is a formal announcement of capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-07-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.